Evidence map›Paper›PMID 25531510›Full record

ArticleMetallomics : integrated biometal science2015

Age- and manganese-dependent modulation of dopaminergic phenotypes in a C. elegans DJ-1 genetic model of Parkinson's disease.

Pan Chen, Margaret R DeWitt, Julia Bornhorst, Felix A Soares, Somshuvra Mukhopadhyay, Aaron B Bowman, Michael Aschner

Open access · bronzeAbstract read
In one paragraph

Article in Metallomics : integrated biometal science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Studying the mechanisms of neurodegeneration:Frontiers in cellular neuroscience · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Biomolecules · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. C. elegans as a model in developmental neurotoxicology.Toxicology and applied pharmacology · 2018
    Review
  18. International journal of environmental research and public health · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 6 countries.

Pan ChenDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA. michael.aschner@einstein.yu.edu.
Margaret R DeWitt
Julia Bornhorst
Felix A Soares
Somshuvra Mukhopadhyay
Aaron B Bowman
Michael Aschner
Albert Einstein College of Medicine · USVanderbilt University Medical Center · USInstitut de Biologie Moléculaire et Cellulaire · FRUniversidade Federal de Santa Maria · BRUniversity of Potsdam · DE

Funding

Mechanisms of Manganese NeurotoxicityR01ES010563 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 2001 to 2026
$11.9M
Mechanisms of Methylmercury Induced Neuron ToxicityR01ES007331 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 1996 to 2026
$10.6M
Role of Mechanisms of Efflux in Manganese Homeostasis and DetoxificationR00ES020844 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI MUKHOPADHYAY, SOMSHUVRA · 2013 to 2015
$747k
NIEHS NIH HHS R00 ES020844NIEHS NIH HHS R01 ES007331NIEHS NIH HHS R01 ES010563
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease, yet its etiology and pathogenesis are poorly understood. PD is characterized by selective dopaminergic (DAergic) degeneration and progressive hypokinetic motor impairment. Mutations in dj-1 cause autosomal recessive early-onset PD. DJ-1 is thought to protect DAergic neurons via an antioxidant mechanism, but the precise basis of this protection has not yet been resolved. Aging and manganese (Mn) exposure are significant non-genetic risk factors for PD. Caenorhabditis elegans (C. elegans) is an optimal model for PD and aging studies because of its simple nervous system, conserved DAergic machinery, and short 20-day lifespan. Here we tested the hypothesis that C. elegans DJ-1 homologues were protective against Mn-induced DAergic toxicity in an age-dependent manner. We showed that the deletion of C. elegans DJ-1 related (djr) genes, djr-1.2, decreased survival after Mn exposure. djr-1.2, the DJ-1 homologue was expressed in DAergic neurons and its deletion decreased lifespan and dopamine (DA)-dependent dauer movement behavior after Mn exposure. We also tested the role of DAF-16 as a regulator of dj-1.2 interaction with Mn toxicity. Lifespan defects resulting from djr-1.2 deletion could be restored to normal by overexpression of either DJR-1.2 or DAF-16. Furthermore, dauer movement alterations after djr-1.2 deletion were abolished by constitutive activation of DAF-16 through mutation of its inhibitor, DAF-2 insulin receptor. Taken together, our results reveal PD-relevant interactions between aging, the PD environmental risk factor manganese, and homologues of the established PD genetic risk factor DJ-1. Our data demonstrate a novel role for the DJ-1 homologue, djr-1.2, in mitigating Mn-dependent lifespan reduction and DA signaling alterations, involving DAF-2/DAF-16 signaling.

Indexed as

Models, GeneticAgingAldehyde OxidoreductasesAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsDisease Models, AnimalDopaminergic NeuronsForkhead Transcription FactorsGene DeletionGreen Fluorescent ProteinsLongevityManganeseModels, BiologicalMovementParkinson DiseaseAldehyde OxidoreductasesCaenorhabditis elegans Proteinsdaf-16 protein, C elegansDJR-1.1 protein, C elegansDJR-1.2 protein, C elegansForkhead Transcription FactorsGreen Fluorescent ProteinsManganese

Identifiers

PMID25531510
PMCPMC4479152
OpenAlexW2138731844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.